Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Renovaro Inc. - Common Stock
(NQ:
RENB
)
1.290
-0.040 (-3.01%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 7, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Renovaro Inc. - Common Stock
< Previous
1
2
3
Next >
RENB Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Renovaro Biosciences Inc. Is Fair to Shareholders
September 29, 2023
From
Halper Sadeh LLC
Via
Business Wire
Renovaro Biosciences and AI Health Company GEDi Cube Sign Definitive Agreement to Combine
September 29, 2023
From
Renovaro Biosciences Inc.
Via
GlobeNewswire
Eliminating Barriers Surrounding Solid Tumors Allows T Cells to Kill Cancerous Cells
September 28, 2023
Via
Investor Brand Network
Why Colon Cancer Is Largely Unresponsive to Immunotherapy
September 22, 2023
Via
Investor Brand Network
BioMedNewsBreaks – IBN’s BioMedWire Highlights NanoVibronix Inc.’s (NASDAQ: NAOV) $5M Private Placement
September 21, 2023
Via
Investor Brand Network
Renovaro BioSciences Inc. (NASDAQ: RENB) Targets Pancreatic Cancer Solution Through Work With GEDI Cube AI Platform, NVIDIA Resources
September 20, 2023
Via
Investor Brand Network
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
UI Research Suggests Immune System Can Be Trained to Combat Solid Tumors
September 18, 2023
Via
Investor Brand Network
BioMedNewsBreaks — Why Renovaro BioSciences Inc. (NASDAQ: RENB) Is ‘One to Watch’
September 15, 2023
Via
Investor Brand Network
Stack Foundation Gives UC San Diego $5M Gift to Advance Gene Therapy
September 12, 2023
Via
Investor Brand Network
Tracking Off-Label Cancer Treatment Could Ease Future Trials, Remedies
September 06, 2023
Via
Investor Brand Network
UC San Diego Researchers Suggest Stem Cell Transplantation Could Treat Alzheimer’s
August 30, 2023
Via
Investor Brand Network
BioMedNewsBreaks — Renovaro BioSciences Inc. (NASDAQ: RENB) Congratulates GEDiCube on New Joint Effort Clinical Trials
August 30, 2023
Via
Investor Brand Network
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Renovaro BioSciences Welcomes GEDiCube Announcement of New Joint Effort
August 30, 2023
From
Renovaro Biosciences Inc.
Via
GlobeNewswire
Renovaro BioSciences Inc. (NASDAQ: RENB) Aims to Unlock Potential Treatments and Cures for Serious Infectious Diseases and Cancer
August 25, 2023
Via
Investor Brand Network
Australia Brings New HIV Infections to Near Zero
August 24, 2023
Via
Investor Brand Network
BioMedNewsBreaks – Renovaro BioSciences Inc. (NASDAQ: RENB) Eyes Clear Path to IND Submission for Innovative Cancer Platform
August 23, 2023
Via
Investor Brand Network
Exposures
Product Safety
Renovaro BioSciences Inc. (NASDAQ: RENB), Immunotherapy Biotech Company, Announces Intention to Unite With AI Tech Developer GEDi Cube, Seen as Major Multiplier Effect in the Fight Against Cancer
August 23, 2023
Via
Investor Brand Network
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
BioMedNewsBreaks – Renovaro BioSciences Inc. (NASDAQ: RENB) Congratulates GEDi Cube on Appointment of Expert in Clinical Medicine and Digital Health
August 21, 2023
Via
Investor Brand Network
Renovaro BioSciences Congratulates GEDi Cube on Appointment of its Chief Medical Officer
August 21, 2023
From
Renovaro Biosciences Inc.
Via
GlobeNewswire
BioMedNewsBreaks – Renovaro BioSciences Inc. (NASDAQ: RENB) CEO Discusses Substantial Scientific, Product Development Advances in Letter to Shareholders
August 18, 2023
Via
Investor Brand Network
Exposures
Product Safety
BioMedNewsBreaks – Renovaro BioSciences Inc. (NASDAQ: RENB) Announces Presentation of ‘Impressive’ Results from Proof-of-Concept Studies
August 17, 2023
Via
Investor Brand Network
BioMedNewsBreaks – Renovaro BioSciences Inc. (NASDAQ: RENB) Eyes Bright Future in Advancing Potentially Curative Therapies
August 16, 2023
Via
Investor Brand Network
Topics
Intellectual Property
Exposures
Intellectual Property
BioMedNewsBreaks – Renovaro BioSciences Inc. (NASDAQ: RENB) Committed to Rapid Advancement of Its Proprietary Oncology Platform
August 15, 2023
Via
Investor Brand Network
Topics
Intellectual Property
Exposures
Intellectual Property
Renovaro BioSciences Inc. (NASDAQ: RENB) Is ‘One to Watch’
August 14, 2023
Via
Investor Brand Network
Renovaro BioSciences (NASDAQ: RENB), GEDi Cube Announce LOI to Merge, Focus on Fight Against Cancer
August 09, 2023
Via
Investor Brand Network
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
BioMedNewsBreaks — Renovaro BioSciences Inc. (NASDAQ: RENB), GEDi Cube Announce LOI to Merge, Focus on Fight Against Cancer
August 09, 2023
Via
Investor Brand Network
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
AI Company GEDi Cube and Renovaro Biosciences Announce a Binding, Exclusive Letter of Intent to Merge, Accelerating Fight Against Cancer
August 09, 2023
From
Renovaro Biosciences Inc.
Via
GlobeNewswire
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.